Biotech's 2025 rebound sets the stage for Denali Therapeutics and two peers, with key FDA decisions and pipeline catalysts ...

The global transition to a hydrogen-based clean energy economy faces a critical bottleneck: current proton exchange membrane ...

An independent examination of the liquid bee-derived metabolism formula featuring berberine, kudzu, royal jelly, and lipase-supporting ingredients from the Ohio-based supplement brand ...

Cities are growing. Forests are shrinking. But what’s happening beneath our feet—in the soil of the very trees that line our ...

Targeting SUMOylation in glioblastoma opens new avenue for therapeutic interventions and biomarker discovery Glioblastoma, a ...

From cholesterol chemistry to muscle pain fears, this guide unpacks how statins work, who they help most, and why concerns ...

Few fruits are as underrated yet profoundly nourishing as papaya . Often seen as a humble breakfast addition, papaya is a ...

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...

Get the latest Moderna (MRNA) stock analysis: balanced risk-reward, new vaccine launches, and pipeline insights. See why we ...

A research-driven evaluation assessing the comparative effectiveness of phosphodiesterase type 5 (PDE5) inhibitors is contributing to ongoing clinical discourse around vascular-mediated functional ...

A new study reveals that antimicrobial resistance is rising worldwide - eroding the effectiveness of last-line antibiotics ...

Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney TransplantationThe application is based on the successful outcome of the pivotal US Phase 3 ConfIdeS trial in highly ...